The science
The formulation question here is what happens to Atopalm's technology when it leaves the emulsion, and the answer explains most of the bottle. Multi-Lamellar Emulsion is a water-in-lipid system in which a synthetic pseudoceramide — myristoyl/palmitoyl oxostearamide/arachamide MEA — assembles with fatty acids, phytosterols and emulsifiers into stacked lamellar bilayers that mimic the stratum corneum's lipid organisation; that structure, not the pseudoceramide alone, is what the brand's clinical work rests on, including a 2024 randomised controlled trial in Dermatol Ther (Heidelb) reporting improved atopic dermatitis severity and barrier measures with an MLE moisturiser. An anhydrous oil has no aqueous phase and no lamellae; the pseudoceramide dissolved in it behaves as a ceramide-like emollient with some occlusive benefit, and the trial evidence does not apply. The base itself is well chosen: squalane, reviewed in Adv Food Nutr Res in 2012, is fully saturated and therefore oxidation-stable, structurally identical to hydrogenated skin squalene, and well tolerated as an emollient; the light esters lower viscosity and spreading resistance, and the four plant oils supply oleic, linoleic and — from meadowfoam — unusually stable C20 to C22 fatty acids. The extracts are misplaced by phase: Tremella fuciformis polysaccharide hydrates by binding water and camu camu's ascorbic acid is water-soluble and unstable in lipid, so neither functions as marketed in an oil. On the primary claim, the 2012 Cochrane review of topical preparations for preventing stretch marks in pregnancy, pooling six trials and 800 women, found no significant reduction in striae development against placebo or no treatment, consistent with striae being dermal tears beyond the reach of a topical. Two safety points are documented. Bergamot oil's 5-methoxypsoralen is a potent UVA photosensitiser, with bullous phototoxic reactions reported in J Am Acad Dermatol in 2001 and the action spectrum characterised in J Dermatol in 1994; furocoumarin-free bergamot exists but is not specified here, and litsea cubeba oil's citral is a recognised contact sensitiser. Hazelnut oil at position three raises the unresolved question of cutaneous nut-oil exposure and infant sensitisation first flagged by the 2003 N Engl J Med analysis associating peanut-oil skin preparations with childhood peanut allergy — contested, but relevant to a product applied to a chest and belly a newborn will contact. No study of this product has been published.
References 5 ShowHide
- Topical preparations for preventing stretch marks in pregnancy — Cochrane Database of Systematic Reviews (2012)
- Efficacy of a Multi-lamellar Emulsion Containing a Synthetic Sphingosine Kinase 1 Activator and Pseudoceramide in Patients with Atopic Dermatitis: A Randomized Controlled Trial — Dermatology and Therapy (2024)
- Biological importance and applications of squalene and squalane — Advances in Food and Nutrition Research (2012)
- Accidental bullous phototoxic reactions to bergamot aromatherapy oil — Journal of the American Academy of Dermatology (2001)
- Factors associated with the development of peanut allergy in childhood — New England Journal of Medicine (2003)